# Duquesne University, Terra Pharm Partner for Cannabis Research > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/duquesne-university-cannabis-research-partnership/ > **Published:** 2026-04-25T08:02:56-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:10:47-04:00 > **Clinical Summary:** Explore the Duquesne University cannabis research partnership with Terra Pharm, advancing clinical cannabis studies and academic-industry collaboration. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic ResearchAcademic PartnershipEvidence DevelopmentIndustry Collaboration[Clinical Trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) Why This Matters Academic-industry partnerships in [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) are essential for generating the rigorous clinical evidence our field desperately needs. When established universities collaborate with licensed cannabis companies, it creates the infrastructure necessary for controlled studies that can inform evidence-based prescribing decisions. Clinical Summary Duquesne University has announced a research partnership with Terra Pharm, a cannabis company, to advance [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) research. This collaboration represents the growing trend of academic institutions partnering with industry to conduct controlled cannabis studies. Such partnerships are becoming increasingly important as traditional research barriers around cannabis continue to limit high-quality [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) and mechanistic studies. Dr. Caplan’s Take “I’m encouraged to see more universities stepping into [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) partnerships — we need academic rigor applied to this medicine. The key will be ensuring these collaborations maintain scientific independence while leveraging industry resources and expertise.” Clinical Perspective 🧠 Clinicians should watch for peer-reviewed publications emerging from partnerships like this, as they may provide more reliable data than industry-sponsored studies alone. Academic oversight typically ensures better study design and more objective analysis, which could translate into actionable clinical guidance for patient care decisions. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Duquesne%20University%2C%20cannabis%20company%20Terra%20Pharm%20partner%20%E2%80%94%20and%20research%20opportunities%20abound%20%40drcaplan&url=https%3A%2F%2Fcedclinic.com%2Fduquesne-university-cannabis-company-terra-pharm-partner-and-research-opportunit%2F)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fduquesne-university-cannabis-company-terra-pharm-partner-and-research-opportunit%2F)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Duquesne%20University%2C%20cannabis%20company%20Terra%20Pharm%20partner%20%E2%80%94%20and%20research%20opportunities%20abound%20via%20%40drcaplan.bsky.social%20https%3A%2F%2Fcedclinic.com%2Fduquesne-university-cannabis-company-terra-pharm-partner-and-research-opportunit%2F)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) 📰 Source: [https://www.post-gazette.com/news/health/2026/04/25/duquesne-university-terra-pharm-partnership/stories/202604260030](https://www.post-gazette.com/news/health/2026/04/25/duquesne-university-terra-pharm-partnership/stories/202604260030) Table of Contents - [FAQ](#FAQ)[What is the CED Clinical Relevance rating system?](#What_is_the_CED_Clinical_Relevance_rating_system) - [What type of research does this involve?](#What_type_of_research_does_this_involve) - [Who is conducting this research?](#Who_is_conducting_this_research) - [What makes this development noteworthy?](#What_makes_this_development_noteworthy) - [What areas does this research cover?](#What_areas_does_this_research_cover) - [Related](#Related) ## FAQ #### What is the CED Clinical Relevance rating system? The CED Clinical Relevance system appears to be a numbered classification that rates clinical findings or developments. Rating #70 indicates “Notable Clinical Interest” for emerging findings or policy developments that warrant close monitoring. #### What type of research does this involve? This involves cannabis-related research conducted through academic partnerships. The research focuses on evidence development and industry collaboration within the [clinical cannabis](https://cedclinic.com/entourage-effect-cannabis-clinical-breeding-benefits/) field. #### Who is conducting this research? The research is being conducted by CED Clinic in collaboration with academic partners. This represents a partnership between clinical practice and academic institutions for cannabis research. #### What makes this development noteworthy? This development has been classified as having “Notable Clinical Interest” meaning it represents emerging findings or policy developments. The collaborative nature involving research, academic partnerships, and industry involvement makes it particularly significant. #### What areas does this research cover? The research encompasses multiple areas including clinical evidence development, academic research partnerships, and industry collaboration. The focus appears to be on advancing the clinical understanding and application of [cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/). [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [New Clinical Insights on Cannabis and Patient Outcomes](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) Discover recent clinical insights that shed light on cannabis effects and patient outcomes, enhancing evidence-based practice. [Read More](https://cedclinic.com/new-clinical-insights-on-cannabis-and-patient-outcomes/) [Feds ease cannabis restrictions—and open options for researchers – KGUN 9](https://cedclinic.com/federal-cannabis-research-policy-changes/) Learn how federal policy changes are expanding research opportunities in cannabis, supporting academic and industry collaborations. [Explore Article](https://cedclinic.com/federal-cannabis-research-policy-changes/) [What sets research-led cannabis developers apart?](https://cedclinic.com/what-sets-research-led-cannabis-developers-apart/) Understand the unique approaches of research-driven cannabis developers and their role in advancing clinical evidence. [Discover More](https://cedclinic.com/what-sets-research-led-cannabis-developers-apart/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).